Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Growth Metrics
Income Statement
Others
Ratios

Cresco Labs (CRLBF) Other Non-Current Liabilities (2020 - 2025)

Cresco Labs (CRLBF) has disclosed Other Non-Current Liabilities for 5 consecutive years, with $83.5 million as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Other Non-Current Liabilities rose 958.61% year-over-year to $83.5 million, compared with a TTM value of $83.5 million through Dec 2024, up 958.61%, and an annual FY2024 reading of $83.5 million, up 958.61% over the prior year.
  • Other Non-Current Liabilities was $83.5 million for Q4 2024 at Cresco Labs, up from $7.9 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $83.5 million in Q4 2024 and bottomed at $7.0 million in Q4 2022.
  • Average Other Non-Current Liabilities over 5 years is $22.8 million, with a median of $7.9 million recorded in 2023.
  • The sharpest move saw Other Non-Current Liabilities dropped 18.18% in 2021, then soared 958.61% in 2024.
  • Year by year, Other Non-Current Liabilities stood at $8.6 million in 2020, then fell by 18.18% to $7.0 million in 2021, then dropped by 0.01% to $7.0 million in 2022, then rose by 12.66% to $7.9 million in 2023, then skyrocketed by 958.61% to $83.5 million in 2024.
  • Business Quant data shows Other Non-Current Liabilities for CRLBF at $83.5 million in Q4 2024, $7.9 million in Q4 2023, and $7.0 million in Q4 2022.